All Pharma News
price-trendAsk Us
Stallergenes Greer Announces Publication of Results for PALFORZIA® Phase 3 Study

Stallergenes Greer Announces Publication of Results for PALFORZIA® Phase 3 Study
BUSINESSWIRE
20 Nov 2023
Share Share
Stallergenes Greer Announces Global Agreement With Nestlé

Stallergenes Greer Announces Global Agreement With Nestlé
BUSINESSWIRE
04 Sep 2023
Share Share
Stallergenes Greer initiates Phase III study of Staloral Birch

Stallergenes Greer initiates Phase III study of Staloral Birch
CLINICAL TRIALS ARENA
26 May 2023
Share Share
Positive Results of EfficAPSI Real-World Study Confirm Significant Benefit

Positive Results of EfficAPSI Real-World Study Confirm Significant Benefit
BUSINESSWIRE
02 Jul 2022
Share Share
Stallergenes Strengthens Precision Medicine Approach in Allergen Immunotherapy

Stallergenes Strengthens Precision Medicine Approach in Allergen Immunotherapy
BUSINESSWIRE
17 Jan 2022
Share Share
Stallergenes Greer Launches CORAP Research Programme

Stallergenes Greer Launches CORAP Research Programme
BUSINESSWIRE
07 Oct 2021
Share Share
Stallergenes Greer, Alyatec enter research collaboration

Stallergenes Greer, Alyatec enter research collaboration
PHARMABIZ
12 Jul 2021
Share Share
Stallergenes Greer Announces that Alustal®

Stallergenes Greer Announces that Alustal®
BUSINESSWIRE
26 Jun 2021
Share Share